250 LARODOPA ROCHE (Larodopa 250 MG)
Generic Name: levodopa
Pill with imprint 250 LARODOPA ROCHE is Pink, Round and has been identified as Larodopa 250 MG. It is supplied by Roche Laboratories.
Larodopa is used in the treatment of parkinson's disease; periodic limb movement disorder; restless legs syndrome and belongs to the drug class dopaminergic antiparkinsonism agents. FDA has not classified the drug for risk during pregnancy. Larodopa 250 MG is not a controlled substance under the Controlled Substances Act (CSA).
Images for 250 LARODOPA ROCHE
Larodopa
- Generic Name
- levodopa
- Imprint
- 250 LARODOPA ROCHE
- Strength
- 250 MG
- Color
- Pink
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roche Laboratories
- National Drug Code (NDC)
- 00004-0057 (Discontinued)
More about Larodopa (levodopa)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
- Other brands
- Inbrija
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.